Claims for Patent: 7,838,524

Summary for Patent: 7,838,524

Title:	Substituted pyrazolyl urea derivatives useful in the treatment of cancer
Abstract:	The present invention relates to compounds of formula (I), pharmaceutical compositions which contain them and methods for treating cancer using compounds of formula (I). ##STR00001##
Inventor(s):	Lee; Wendy (South San Francisco, CA), Ladouceur; Gaetan (Guilford, CT), Dumas; Jacques (Waltham, MA), Smith; Roger (Madison, CT), Ying; Shihong (Orange, CT), Wang; Gan (Wallingord, CT), Chen; Zhi (Lyndhurst, NJ), Liu; Qingjie (Orange, CT), Mokdad; Holia Hatoum (Guilford, CT)
Assignee:	Bayer Healthcare LLC (Tarrytown, NY)
Application Number:	11/579,093
Patent Claims:	1. A compound of Formula I, or a salt, stereoisomer, alkyl ester prodrug or phenyl(C.sub.1-C.sub.5) alkyl ester prodrug thereof, ##STR00341## wherein R.sup.1 and R.sup.2 are independently: (a) hydrogen; (b) (C.sub.1-C.sub.5)alkyl, optionally substituted with one or more of hydroxy or fluoro; or (c) halogen; A is phenyl, pyridine, or pyrimidine, optionally substituted with 1 or 2 substituents that are independently (C.sub.1-C.sub.5)alkyl, (C.sub.1-C.sub.5)alkoxy, (C.sub.1-C.sub.5)haloalkyl, (C.sub.1-C.sub.5)haloalkoxy, or halogen; B is phenylene or naphthylene, optionally substituted with 1 to 4 substituents that are independently (C.sub.1-C.sub.5)alkyl, (C.sub.1-C.sub.5)alkoxy, (C.sub.1-C.sub.5)haloalkyl, (C.sub.1-C.sub.5)haloalkoxy, or halogen; L is a bridging group which is --O--, --S--, or --CH.sub.2--. M is phenyl, pyridine or pyrimidine, optionally substituted with 1 to 3 substituents that are independently: (1) (C.sub.1-C.sub.5)alkyl; (2) (C.sub.1-C.sub.5)haloalkyl; (3) --O--R.sup.3; (4) --NR.sup.3R.sup.4; (5) halogen; (6) --C(O)NR.sup.3R.sup.4; (7) cyano; (8) C(O)R.sup.3; (9) --C.ident.C--R.sup.3 or (10) nitro; n is zero or one and X is: (1) --O--; (2) --SO.sub.2--; (3) --NR.sup.5--; (4) --NR.sup.5--SO.sub.2--; (5) --N(SO.sub.2NR.sup.7R.sup.8)--; (6) --SO.sub.2--NR.sup.5--; (7) --NR.sup.5--C(O)--; (8) --C(O)--NR.sup.5--; (9) --C(O)-- or (10) a single bond; Y is a linear or branched C.sub.1 to C.sub.6 alkyl fragment that is substituted with one or two Z groups, where each Z group is independently: (1) --OR.sup.6; (2) --O--C(O)--R.sup.6; (3) --NR.sup.7R.sup.8; (4) --SO.sub.2--(C.sub.1-C.sub.5)alkyl; (5) --C(O)--O--R.sup.6; (6) --NH--C(O)--R.sup.6; (7) --C(O)--NR.sup.7R.sup.8 or (8) a monocyclic, saturated, partially saturated, or aromatic heterocycle of 5-7 ring atoms containing at least one heteroatom selected from N, O, or S, that is optionally substituted with 1 to 3 substituents selected from (C.sub.1-C.sub.5)alkyl, (C.sub.1-C.sub.5)haloalkyl, hydroxy, amino, halogen, or oxo; with the proviso that when n is zero and X is --O--, --NR.sup.3--, or a single bond, then Z is not morpholine, piperidine, imidazole, or tetrazole; with the further proviso that when n is zero and X is a single bond, then Z is not --NR.sup.7R.sup.8; R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are each independently hydrogen or (C.sub.1-C.sub.5)alkyl optionally substituted with hydroxy; and R.sup.7 and R.sup.8 are independently hydrogen, or (C.sub.1-C.sub.5)alkyl optionally substituted with hydroxy; or the group --NR.sup.7R.sup.8 forms a monocyclic saturated heterocyclic ring having 5 to 7 ring atoms optionally substituted on a carbon atom with hydroxy, where, in addition to the nitrogen atom in the group --NR.sup.7R.sup.8, zero to two of the other ring atoms is a hetero atom selected from N, O and S, and the remaining ring atoms are carbon. 2. A compound as in claim 1 wherein R.sup.1 is (C.sub.1-C.sub.5)alkyl and R.sup.2 is hydrogen. 3. A compound as in claim 1 wherein R.sup.1 is tert-butyl, isopropyl, or cyclopentyl and R.sup.2 is hydrogen. 4. A compound as in claim 1 wherein A is phenyl or pyridine optionally substituted with 1 or 2 substituents which are independently (C.sub.1-C.sub.5)alkyl, (C.sub.1-C.sub.5)alkoxy or halogen. 5. A compound as in claim 1 wherein -A-(CH.sub.2).sub.n--X--Y is a structure of formulae 1x or 1xx: ##STR00342## wherein R.sup.a is methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, bromine, chlorine or fluorine and n, X and Y are as defined in claim 1 and the pyrazole ring and the group, --(CH.sub.2).sub.n--X--Y are not bound to contiguous ring carbons of A, but rather have 1 or 2 ring carbons separating them. 6. A compound as in claim 1 wherein B is phenylene, optionally substituted with 1 to 2 halogen atoms and is of the formula 2x: ##STR00343## wherein R.sup.b is fluorine or chlorine and the urea group and the bridging group are not bound to contiguous ring carbons of B, but rather have 1 or 2 ring carbons separating them. 7. A compound as in claim 1 wherein B is of one of the following formulae: ##STR00344## 8. A compound as in claim 1 wherein M is of one of the following formulas: ##STR00345## wherein R.sup.c is: (1) (C.sub.1-C.sub.5)alkyl; (2) (C.sub.1-C.sub.5)haloalkyl; (3) --O--R.sup.3; (4) --NR.sup.3R.sup.4; (5) halogen; (6) --C(O)NR.sup.3R.sup.4; (7) cyano; (8) C(O)R.sup.3; (9) --C.ident.C--R.sup.3 or (10) nitro. 9. A compound of claim 1 wherein X is --O--; --NR.sup.5--; --NR.sup.5--C(O)--; --C(O)--NR.sup.5-- or a single bond. 10. A compound of claim 1 wherein Y is a linear or branched C.sub.1 to C.sub.4 alkyl fragment that is substituted with one Z group selected from --OR.sup.6; --NR.sup.7R.sup.8; --NH--C(O)--R.sup.6 or --C(O)--NR.sup.7R.sup.8. 11. A compound of claim 1 wherein Y is methylene, ethylene, n-propylene, or n-butylene. 12. A compound as in claim 1 wherein R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are each independently hydrogen, methyl, ethyl, propyl or butyl, optionally substituted with hydroxy. 13. A compound as in claim 1, wherein Z is --NR.sup.7R.sup.8, which is in the form of a monocyclic saturated heterocyclic ring group selected from pyrrolidine, piperidine, azepane, morpholine, thiomorpholine, piperazine, and homopiperazine, each optionally substituted on a carbon atom with hydroxy. 14. A compound of claim 1 wherein, R.sup.7 and R.sup.8 are each independently hydrogen, methyl, ethyl, propyl or butyl, optionally substituted with hydroxy. 15. A compound of Formula II, or a salt or a stereoisomer thereof, ##STR00346## wherein R.sup.b is fluorine or chlorine; R.sup.1 and R.sup.2 are independently: (a) hydrogen; (b) (C.sub.1-C.sub.5)alkyl, optionally substituted with one or more hydroxy or fluoro; or (c) halogen. R.sup.c is: (C.sub.1-C.sub.5)alkyl; (C.sub.1-C.sub.5)haloalkyl; --O--R.sup.3; --NR.sup.3R.sup.4; halogen; --C(O)NR.sup.3R.sup.4; cyano; C(O)R.sup.3; --C.ident.C--R.sup.3 or nitro; A is phenyl, pyridine, or pyrimidine, optionally substituted with 1 or 2 substituents that are independently (C.sub.1-C.sub.5)alkyl, (C.sub.1-C.sub.5)alkoxy, (C.sub.1-C.sub.5)haloalkyl, (C.sub.1-C.sub.5)haloalkoxy or halogen; X is: (1) --O--; (2) --SO.sub.2--; (3) --NR.sup.5--; (4) --NR.sup.5--SO.sub.2--; (5) --N(SO.sub.2NR.sup.7R.sup.8)--; (6) --SO.sub.2--NR.sup.5--; (7) --NR.sup.5--C(O)--; (8) --C(O)--NR.sup.5--; (9) --C(O)-- or (10) a single bond; Y is a linear or branched C.sub.1 to C.sub.6 alkyl fragment that is substituted with one or two Z groups, where each Z group is independently: (1) --OR.sup.6; (2) --O--C(O)--R.sup.6; (3) --NR.sup.7R.sup.8; (4) --SO.sub.2--(C.sub.1-C.sub.5)alkyl; (5) --C(O)--O--R.sup.6; (6) --NH--C(O)--R.sup.6; (7) --C(O)--NR.sup.7R.sup.8; or (8) a monocyclic, saturated, partially saturated, or aromatic heterocycle of 5-7 ring atoms containing at least one heteroatom selected from N, O, or S, that is optionally substituted with 1 to 3 substituents selected from (C.sub.1-C.sub.5)alkyl, (C.sub.1-C.sub.5)haloalkyl, hydroxy, amino, halogen, or oxo; with the proviso that when n is zero and X is --O--, --NR.sup.3--, or a single bond, then Z is not morpholine, piperidine, imidazole, or tetrazole; with the further proviso that when n is zero and X is a single bond, then Z is not --NR.sup.7R.sup.8; R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are each independently hydrogen or (C.sub.1-C.sub.5)alkyl optionally substituted with hydroxy; R.sup.7 and R.sup.8 are independently hydrogen, or (C.sub.1-C.sub.5)alkyl optionally substituted with hydroxy; or the group --NR.sup.7R.sup.8 forms a monocyclic saturated heterocyclic ring having 5 to 7 ring atoms, optionally substituted on a carbon atom with hydroxy where, in addition to the nitrogen atom attached to the rest of the molecule, zero to two of the other ring atoms is a hetero atom selected from N, O and S, and the remaining ring atoms are carbon. 16. A compound as in claim 15 wherein R.sup.1 is (C.sub.1-C.sub.5)alkyl and R.sup.2 is hydrogen. 17. A compound as in claim 15 wherein R.sup.1 is tert-butyl, isopropyl, or cyclopentyl and R.sup.2 is hydrogen. 18. A compound as in claim 15 wherein A is phenyl or pyridine optionally substituted with 1 or 2 substituents which are independently (C.sub.1-C.sub.5)alkyl, (C.sub.1-C.sub.5)alkoxy or halogen. 19. A compound as in claim 15 wherein -A-(CH.sub.2).sub.n--X--Y is a structure of formulae 1x or 1xx: ##STR00347## wherein R.sup.a is methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, bromine, chlorine or fluorine and n is zero or one and X is: (1) --O--; (2) --SO.sub.2--; (3) --NR.sup.5--; (4) --NR.sup.5--SO.sub.2--; (5) --N(SO.sub.2NR.sup.7R.sup.8)--; (6) --SO.sub.2--NR.sup.5--; (7) --NR.sup.5--C(O)--; (8) --C(O)--NR.sup.5--; (9) --C(O)-- or (10) a single bond; Y is a linear or branched C.sub.1 to C.sub.6 alkyl fragment that is substituted with one or two Z groups, where each Z group is independently: (1) --OR.sup.6; (2) --O--C(O)--R.sup.6; (3) --NR.sup.7R.sup.8; (4) --SO.sub.2--(C.sub.1-C.sub.5)alkyl; (5) --C(O)--O--R.sup.6; (6) --NH--C(O)--R.sup.6; (7) --C(O)--NR.sup.7R.sup.8 or (8) a monocyclic, saturated, partially saturated, or aromatic heterocycle of 5-7 ring atoms containing at least one heteroatom selected from N, O, or S, that is optionally substituted with 1 to 3 substituents selected from (C.sub.1-C.sub.5)alkyl, (C.sub.1-C.sub.5)haloalkyl, hydroxy, amino, halogen, or oxo; with the proviso that when n is zero and X is --O--, --NR.sup.3--, or a single bond, then Z is not morpholine, piperidine, imidazole, or tetrazole; with the further proviso that when n is zero and X is a single bond, then Z is not --NR.sup.7R.sup.8; and the pyrazole ring and the group, --(CH.sub.2).sub.n--X--Y, are not bound to contiguous ring carbons of A. 20. A compound of claim 15 wherein Y is a linear or branched C.sub.1 to C.sub.4 alkyl fragment that is substituted with one Z group selected from --OR.sup.6; --NR.sup.7R.sup.8; --NH--C(O)--R.sup.6 or --C(O)--NR.sup.7R.sup.8. 21. A compound of claim 15 wherein Y is methylene, ethylene, n-propylene, or n-butylene. 22. A compound as in claim 15 wherein R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are each independently hydrogen, methyl, ethyl, propyl or butyl, optionally substituted with hydroxy. 23. A compound as in claim 15, wherein Z is --NR.sup.7R.sup.8, which is in the form of a monocyclic saturated heterocyclic ring group selected from pyrrolidine, piperidine, azepane, morpholine, thiomorpholine, piperazine, and homopiperazine, each optionally substituted on a carbon atom with hydroxy. 24. A compound of claim 15 wherein, R.sup.7 and R.sup.8 are each independently selected from hydrogen, methyl, ethyl, propyl or butyl, optionally substituted with hydroxy. 25. A compound of Formulae III or IV, or a salt or a stereoisomer thereof: ##STR00348## wherein R.sup.a is methyl, ethyl, propyl, butyl, methoxy, ethoxy, propoxy, bromine, chlorine or fluorine; R.sup.c is selected from (C.sub.1-C.sub.5)alkyl; (C.sub.1-C.sub.5)haloalkyl; --O--R.sup.3; --NR.sup.3R.sup.4; halogen; --C(O)NR.sup.3R.sup.4; cyano; C(O)R.sup.3; --C.ident.C--R.sup.3; or nitro; and R.sup.z is tert-butyl, isopropyl, or cyclopentyl; n is zero or one and X is: --O--; --SO.sub.2--; --NR.sup.5--; --NR.sup.5--SO.sub.2--; --N(SO.sub.2NR.sup.7R.sup.8)--; --SO.sub.2--NR.sup.5--; --NR.sup.5--C(O)--; --C(O)--NR.sup.5--; --C(O)--; or a single bond; Y is a linear or branched C.sub.1 to C.sub.6 alkyl fragment that is substituted with one or two Z groups, where each Z group is independently selected from: (1) --OR.sup.6; (2) --O--C(O)--R.sup.6; (3) --NR.sup.7R.sup.8; (4) --SO.sub.2--(C.sub.1-C.sub.5)alkyl; (5) --C(O)--O--R.sup.6; (6) --NH--C(O)--R.sup.6; (7) --C(O)--NR.sup.7R.sup.8; or (8) a monocyclic, saturated, partially saturated, or aromatic heterocycle of 5-7 ring atoms containing at least one heteroatom which is N, O, or S, that is optionally substituted with 1 to 3 substituents selected from (C.sub.1-C.sub.5)alkyl, (C.sub.1-C.sub.5)haloalkyl, hydroxy, amino, halogen, or oxo; with the proviso that when n is zero and X is --O--, --NR.sup.3--, or a single bond, then Z is not morpholine, piperidine, imidazole, or tetrazole; with the further proviso that when n is zero and X is a single bond, then Z is not --NR.sup.7R.sup.8; R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are each independently hydrogen or (C.sub.1-C.sub.5)alkyl optionally substituted with hydroxy; R.sup.7 and R.sup.8 are independently hydrogen, or (C.sub.1-C.sub.5)alkyl optionally substituted with hydroxy; or the group --NR.sup.7R.sup.8 forms a monocyclic saturated heterocyclic ring having 5 to 7 ring atoms, where, in addition to the nitrogen atom attached to the group --NR.sup.7R.sup.8, zero to two of the other ring atoms is a hetero atom selected from N, O and S, and the remaining ring atoms are carbon. 26. A compound of claim 25 wherein Y is a linear or branched C.sub.1 to C.sub.4 alkyl fragment that is substituted with one Z group which is --OR.sup.6; --NR.sup.7R.sup.8; --NH--C(O)--R.sup.6 or --C(O)--NR.sup.7R.sup.8. 27. A compound of claim 25 wherein Y is methylene, ethylene, n-propylene or n-butylene. 28. A compound as in claim 25 wherein R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are each independently hydrogen, methyl, ethyl, propyl or butyl, optionally substituted with hydroxy. 29. A compound as in claim 25, wherein Z is --NR.sup.7R.sup.8, which is in the form of a monocyclic saturated heterocyclic ring group selected from pyrrolidine, piperidine, azepane, morpholine, thiomorpholine, piperazine, and homopiperazine, each optionally substituted on a carbon atom with hydroxy. 30. A compound of claim 25 wherein, R.sup.7 and R.sup.8 are each independently hydrogen or methyl, ethyl, propyl or butyl, optionally substituted with hydroxy. 31. A compound of Formula V and VI, or a salt or a stereoisomer thereof: ##STR00349## wherein Hal is bromine, chlorine or fluorine; n is zero or one; X is: --O--; --NR.sup.5--; --NR.sup.5--C(O)--; --C(O)--NR.sup.5-- or a single bond; and Y is: methylene, ethylene, n-propylene or n-butylene substituted with one Z group which is: --OR.sup.6; --NR.sup.7R.sup.8; --NH--C(O)--R.sup.6 or --C(O)--NR.sup.7R.sup.8 with the proviso that when n is zero and X is a single bond, then Z is not --NR.sup.7R.sup.8 R.sup.5 and R.sup.6 are each independently selected from hydrogen, methyl, ethyl, propyl or butyl, optionally substituted with hydroxy and R.sup.7 and R.sup.8 are each independently selected from hydrogen, methyl, ethyl, propyl or butyl, optionally substituted with hydroxy. 32. The following compounds: 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-pyrrolidin-1-ylethyl)benzamide N-{3-tert-butyl-1-[4-(2-methoxyethoxy)phenyl]-1H-pyrazol-5-yl}-N'-[4-(pyr- idin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-methoxyethoxy)phenyl]-1H-pyrazol-5-yl}-N'-{2-fluo- ro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-tert-butyl-1-{4-[2-(diethylamino)ethoxy]phenyl}-1H-pyrazol-5-yl)-N'-- [4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-piperidin-4-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'-- [4-(pyridin-3-yloxy)phenyl]urea N-{3-tert-butyl-1-[3-(3-hydroxypropoxy)phenyl]-1H-pyrazol-5-yl}-N'-[4-(py- ridin-4-yloxy)phenyl]urea N-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-3-methoxypropanamide N-(3-tert-butyl-1-{4-[(2-methoxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[- 4-(pyridin-4-yloxy)phenyl]urea 4-[(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)amino]-2,2-dimethyl-4-oxobutanoic acid N-(3-tert-butyl-1-{4-[(4-hydroxy-3,3-dimethylbutyl)amino]phenyl}-1H-pyraz- ol-5-yl)-N'-[4-(pyridin-4-yloxy)phenyl]urea N-(3-tert-butyl-1-{3-[(3-hydroxypropyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-- [4-(pyridin-4-yloxy)phenyl]urea N-(3-tert-butyl-1-{3-[[(dimethylamino)sulfonyl] (3-hydroxypropyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[4-(pyridin-4-yloxy)ph- enyl]urea N-(1-{3-[bis(2-hydroxyethyl)amino]phenyl}-3-tert-butyl-1H-pyrazo- l-5-yl)-N'-[4-(pyridin-4-yloxy)phenyl]urea N-{1-[4-(aminomethyl)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-N'-[4-(pyridin- -4-yloxy)phenyl]urea N-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}benzyl)-2-methoxyacetamide N-[3-tert-butyl-1-(4-{[(2-methoxyethyl)amino]methyl}phenyl)-1H-pyrazol-5-- yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea N-[1-(4-{[bis(2-hydroxyethyl)amino]methyl}phenyl)-3-tert-butyl-1H-pyrazol- -5-yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea N-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}benzyl)glycinamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-[(2,2-dimethyl-1,3-dioxolan-4-yl)methy- l]benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]benzamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(2,3-dihydroxypropyl)benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2,3-dihydroxypropyl)benzamide N-{3-tert-butyl-1-[4-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-N'-{2-fluoro- -4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-tert-butyl-1-{4-[(2-methoxyethoxy)methyl]phenyl}-1H-pyrazol-5-yl)-N'- -{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea 4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-2-methyl-N-(2-morpholin-4-ylethyl)benzen- esulfonamide ethyl(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amin- o]-1H-pyrazol-1-yl}phenyl)acetate (4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H- -pyrazol-1-yl}phenyl)acetic acid N-{3-tert-butyl-1-[4-(2-hydroxyethyl)phenyl]-1H-pyrazol-5-yl}-N'-[4-(pyri- din-4-yloxy)phenyl]urea N-[3-tert-butyl-1-(4-{2-[(3S)-3-hydroxypyrrolidin-1-yl]-2-oxoethyl}phenyl- )-1H-pyrazol-5-yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea N-[3-tert-butyl-1-(4-{2-[(3S)-3-hydroxypyrrolidin-1-yl]ethyl}phenyl)-1H-p- yrazol-5-yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea methyl N-[(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)acetyl]-L-serinate N-[(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)acetyl]-L-serine N-{3-tert-butyl-1-[4-(2-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino}ethyl)ph- enyl]-1H-pyrazol-5-yl}-N'-[4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-piperidin-1-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'-- [4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-morpholin-4-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'-- [4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(3-morpholin-4-ylpropoxy)phenyl]-1H-pyrazol-5-yl}-N'- -{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[4-(3-morpholin-4-ylpropoxy)phenyl]-1H-pyrazol-5-yl}-N'- -[4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(3-morpholin-4-ylpropoxy)phenyl]-1H-pyrazol-5-yl}-N'- -[4-(pyridin-3-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(tetrahydro-2H-pyran-4-ylmethoxy)phenyl]-1H-pyrazol-- 5-yl}-N'-[4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(tetrahydro-2H-pyran-4-ylmethoxy)phenyl]-1H-pyrazol-- 5-yl}-N'-[4-(pyridin-3-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(tetrahydro-2H-pyran-4-ylmethoxy)phenyl]-1H-pyrazol-- 5-yl}-N'-{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[4-(3-hydroxypropoxy)phenyl]-1H-pyrazol-5-yl}-N'-{2-flu- oro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[4-(3-hydroxypropoxy)phenyl]-1H-pyrazol-5-yl}-N'-[4-(py- ridin-3-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(3-hydroxypropoxy)phenyl]-1H-pyrazol-5-yl}-N'-[4-(py- ridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'- -[4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'- -[4-(pyridin-3-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'- -{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[4-(2-piperidin-4-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'-- {2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea butyl 4-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenoxy)butanoate butyl 4-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)phenoxy]butanoate N-{1-[4-(2-aminoethoxy)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-N'-{2-fluoro- -4-[(2-methylpyridin-4-yl)oxy]phenyl}urea 4-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)phenoxy]butanoic acid 4-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenoxy)butanoic acid N-{3-tert-butyl-1-[4-(2-piperidin-4-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'-- [4-(pyridin-4-yloxy)phenyl]urea N-{1-[4-(2-aminoethoxy)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-N'-[4-(pyrid- in-4-yloxy)phenyl]urea N-{1-[4-(2-aminoethoxy)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-N'-[4-(pyrid- in-3-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-hydroxyethoxy)phenyl]-1H-pyrazol-5-yl}-N'-[4-(pyr- idin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-hydroxyethoxy)phenyl]-1H-pyrazol-5-yl}-N'-{2-fluo- ro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[4-(2-hydroxyethoxy)phenyl]-1H-pyrazol-5-yl}-N'-[4-(pyr- idin-3-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2,3-dihydroxypropoxy)phenyl]-1H-pyrazol-5-yl}-N'-[4- -(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2,3-dihydroxypropoxy)phenyl]-1H-pyrazol-5-yl}-N'-{2- -fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[3-(3-morpholin-4-ylpropoxy)phenyl]-1H-pyrazol-5-yl}-N'- -[4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[3-(3-morpholin-4-ylpropoxy)phenyl]-1H-pyrazol-5-yl}-N'- -[4-(pyridin-3-yloxy)phenyl]urea N-{3-tert-butyl-1-[3-(3-morpholin-4-ylpropoxy)phenyl]-1H-pyrazol-5-yl}-N'- -{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[3-(3-hydroxypropoxy)phenyl]-1H-pyrazol-5-yl}-N'-{2-flu- oro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[3-(3-hydroxypropoxy)phenyl]-1H-pyrazol-5-yl}-N'-[4-(py- ridin-3-yloxy)phenyl]urea N-{3-tert-butyl-1-[3-(2-pyrrolidin-1-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'- -{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[3-(2-pyrrolidin-1-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'- -[4-(pyridin-3-yloxy)phenyl]urea N-{3-tert-butyl-1-[3-(2-pyrrolidin-1-ylethoxy)phenyl]-1H-pyrazol-5-yl}-N'- -[4-(pyridin-4-yloxy)phenyl]urea N-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)phenyl]-3-methoxypropanamide N-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-2-methoxyacetamide N-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)phenyl]-2-methoxyacetamide 2-[(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)amino]-2-oxoethyl acetate 2-bromo-N-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl- )amino]-1H-pyrazol-1-yl}phenyl)acetamide N-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-2-morpholin-4-ylacetamide N-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-2-pyrrolidin-1-ylacetamide N-(3-tert-butyl-1-{4-[(2-morpholin-4-ylethyl)amino]phenyl}-1H-pyrazol-5-y- l)-N'-[4-(pyridin-4-yloxy)phenyl]urea N-(4-[3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-2-methoxyacetamide N-(3-tert-butyl-1-{4-[(2-hydroxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[- 4-(pyridin-4-yloxy)phenyl]urea N-(3-tert-butyl-1-{4-[(2-hydroxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[- 4-(pyridin-3-yloxy)phenyl]urea N-(3-tert-butyl-1-{4-[(2-methoxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[- 4-(pyridin-3-yloxy)phenyl]urea N-(3-tert-butyl-1-{4-[(3-hydroxypropyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-- [4-(pyridin-4-yloxy)phenyl]urea N-(3-tert-butyl-1-{4-[(3-hydroxypropyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-- [4-(pyridin-3-yloxy)phenyl]urea 4-[(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)amino]-4-oxobutanoic acid 4-[(4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)amino]-4-oxobutanoic acid 4-[(4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)amino]-2,2-dimethyl-4-oxobutanoic acid N-(3-tert-butyl-1-{4-[(2-hydroxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-{- 2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-tert-butyl-1-{4-[(3-hydroxypropyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-- {2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-tert-butyl-1-{4-[(2-methoxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-{- 2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-tert-butyl-1-{4-[[(dimethylamino)sulfonyl] (2-hydroxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[4-(pyridin-4-yloxy)phe- nyl]urea N-(3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl- )amino]-1H-pyrazol-1-yl}phenyl)-2-methoxyacetamide N-(3-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-2-methoxyacetamide N-(3-tert-butyl-1-{3-[(2-hydroxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[- 4-(pyridin-4-yloxy)phenyl]urea N-(3-tert-butyl-1-{3-[(2-hydroxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[- 4-(pyridin-3-yloxy)phenyl]urea N-(3-tert-butyl-1-{3-[(2-methoxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[- 4-(pyridin-4-yloxy)phenyl]urea N-(3-tert-butyl-1-{3-[(2-methoxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[- 4-(pyridin-3-yloxy)phenyl]urea N-(3-tert-butyl-1-{3-[(3-hydroxypropyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-- [4-(pyridin-3-yloxy)phenyl]urea 4-[(3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)amino]-4-oxobutanoic acid 4-[(3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)amino]-2,2-dimethyl-4-oxobutanoic acid 4-[(3-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)amino]-4-oxobutanoic acid 4-[(3-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)amino]-2,2-dimethyl-4-oxobutanoic acid N-[3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)phenyl]-2-methoxyacetamide N-(3-tert-butyl-1-{3-[(2-hydroxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-{- 2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-tert-butyl-1-{3-[(3-hydroxypropyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-- {2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-tert-butyl-1-{3-[(2-methoxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-{- 2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-2-morpholin-4-ylacetamide N-(3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-2-(1H-imidazol-1-yl)acetamide N-(3-tert-butyl-1-{3-[[(dimethylamino)sulfonyl] (2-hydroxyethyl)amino]phenyl}-1H-pyrazol-5-yl)-N'-[4-(pyridin-4-yloxy)phe- nyl]urea N-(3-tert-butyl-1-{3-[(2-morpholin-4-ylethyl)amino]phenyl}-1H-pyr- azol-5-yl)-N'-[4-(pyridin-4-yloxy)phenyl]urea 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-methoxyethyl)benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-methoxyethyl)-N-methylbenzamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-methyl-N-[2-(methylsulfonyl)ethyl]benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(4-pyrrolidin-1-ylbutyl)benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-morpholin-4-ylethyl)benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[3-(diethylamino)propyl]benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[2-(dimethylamino)ethyl]benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(3-pyrrolidin-1-ylpropyl)benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[2-(1H-pyrazol-1-yl)ethyl]benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[3-(1H-imidazol-1-yl)propyl]benzamide 4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(4-pyrrolidin-1-ylbutyl)benzamide 4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-[3-(diethylamino)propyl]benzamide 4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(2-morpholin-4-ylethyl)benzamide 4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- -carbonyl]amino}-1H-pyrazol-1-yl)-N-(2-pyrrolidin-1-ylethyl)benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[3-(diethylamino)propyl]benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-morpholin-4-ylethyl)benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(4-pyrrolidin-1-ylbutyl)benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-pyrrolidin-1-ylethyl)benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[2-(dimethylamino)ethyl]benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-methyl-N-[2-(methylsulfonyl)ethyl]benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-pyrrolidin-1-ylethyl)benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[3-(diethylamino)propyl]benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-methoxyethyl)benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(tetrahydrofuran-2-ylmethyl)benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-{[6-(trifluoromethyl)pyridin-3-yl]methyl}benzamide N-[2-(acetylamino)ethyl]-3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]- amino}-carbonyl)amino]-1H-pyrazol-1-yl}benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[3-(1H-imidazol-1-yl)propyl]benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[2-(2-hydroxyethoxy)ethyl]benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[2-(1-methylpyrrolidin-2-yl)ethyl]benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(3-hydroxy-2,2-dimethylpropyl)benzamide tert-butyl 4-{[(3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)-amin- o]-1H-pyrazol-1-yl}benzoyl)amino]methyl}piperidine-1-carboxylate 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(piperidin-4-ylmethyl)benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(3-hydroxypropyl)benzamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(3-hydroxypropyl)benzamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(2-hydroxyethyl)benzamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-hydroxyethyl)benzamide N-[2-(acetylamino)ethyl]-3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyrid- in-4-yl)oxy]phenyl}amino)carbonyl]amino}-1H-pyrazol-1-yl)benzamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-[3-(1H-imidazol-1-yl)propyl]benzamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(tetrahydrofuran-2-ylmethyl)benzamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- -carbonyl]amino}-1H-pyrazol-1-yl)-N-(2-pyridin-4-ylethyl)benzamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- -carbonyl]amino}-1H-pyrazol-1-yl)-N-[3-(diethylamino)propyl]benzamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]benz- amide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}a- mino)carbonyl]-amino}-1H-pyrazol-1-yl)-N-(2-pyrrolidin-1-ylethyl)benzamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(4-pyrrolidin-1-ylbutyl)benzamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(3-hydroxy-2,2-dimethylpropyl)benzamid- e 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino- )carbonyl]-amino}-1H-pyrazol-1-yl)-N-(piperidin-4-ylmethyl)benzamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(tetrahydrofuran-2-ylmethyl)benzenesulfonamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-morpholin-4-ylethyl)benzenesulfonamide 4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(2-morpholin-4-ylethyl)benzenesulfonam- ide 4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)carbonyl]-amino}-1H-pyrazol-1-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]b- enzenesulfonamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[2-(1-methylpyrrolidin-2-yl)ethyl]benzenesulfonamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-2-methyl-N-(2-morpholin-4-ylethyl)benzene sulfonamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(tetrahydrofuran-2-ylmethyl)-2-(trifluoromethoxy)benzene sulfonamide 4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(tetrahydrofuran-2-ylmethyl)-2-(triflu- oromethoxy)-benzenesulfonamide 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-2-methyl-N-(tetrahydrofuran-2-ylmethyl)benzenesulfonamide 4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-2-methyl-N-(tetrahydrofuran-2-ylmethyl)-- benzenesulfonamide 4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]amino}-1H-pyrazol-1-yl)-N-(tetrahydrofuran-2-ylmethyl)benzenesulf- onamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)ami- no]-1H-pyrazol-1-yl}-N-(2-methoxyethyl)benzenesulfonamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-(2-methoxyethyl)benzenesulfonamide 3-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-(2-methoxyethyl)benzenesulfonamide 3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-- pyrazol-1-yl}-N-[2-(dimethylamino)ethyl]benzenesulfonamide 3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino)- carbonyl]-amino}-1H-pyrazol-1-yl)-N-[2-(dimethylamino)ethyl]benzenesulfona- mide N-{1-[4-(aminomethyl)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-N'-[4-(pyr- idin-3-yloxy)phenyl]urea N-(4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}benzyl)-2-methoxyacetamide N-{1-[4-(aminomethyl)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-N'-{2-fluoro-4- -[(2-methylpyridin-4-yl)oxy]phenyl}urea N-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)benzyl]-2-methoxyacetamide N-[3-tert-butyl-1-(4-{[(2-methoxyethyl)amino]methyl}phenyl)-1H-pyrazol-5-- yl]-N'-{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-[1-(4-{[bis(2-hydroxyethyl)amino]methyl}phenyl)-3-tert-butyl-1H-pyrazol- -5-yl]-N'-[4-(pyridin-3-yloxy)phenyl]urea N-[1-(4-{[bis(2-hydroxyethyl)amino]methyl}phenyl)-3-tert-butyl-1H-pyrazol- -5-yl]-N'-{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-[1-(4-{[bis(3-hydroxypropyl)amino]methyl}phenyl)-3-tert-butyl-1H-pyrazo- l-5-yl]N'-[4-(pyridin-4-yloxy)phenyl]urea N-[1-(4-{[bis(3-hydroxypropyl)amino]methyl}phenyl)-3-tert-butyl-1H-pyrazo- l-5-yl]-N'-[4-(pyridin-3-yloxy)phenyl]urea N-[1-(4-{[bis(3-hydroxypropyl)amino]methyl}phenyl)-3-tert-butyl-1H-pyrazo- l-5-yl]-N'-{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N2-acetyl-N-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbon- yl)-amino]-1H-pyrazol-1-yl}benzyl)glycinamide N-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}benzyl)-2-(1-methyl-1H-imidazol-4-yl)acetamide N-(4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}benzyl)glycinamide N-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)benzyl]acetamide N2-acetyl-N-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]- phenyl}-amino)carbonyl]amino}-1H-pyrazol-1-yl)benzyl]glycinamide N-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)benzyl]-2-(1-methyl-1H-imidazol-4-yl)a- cetamide N-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]ph- enyl}amino)-carbonyl]amino}-1H-pyrazol-1-yl)benzyl]-1-methyl-1H-imidazole-- 4-carboxamide N2-acetyl-N-(4-{3-tert-butyl-5-[({[4-(pyridin-3-yloxy)phenyl]amino}carbon- yl)-amino]-1H-pyrazol-1-yl}benzyl)glycinamide N-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)benzyl]alaninamide N-[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)benzyl]glycinamide N-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}benzyl)alaninamide N-[3-tert-butyl-1-(3-{[(2-hydroxyethyl)amino]methyl}phenyl)-1H-pyrazol-5-- yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea N-{1-[3-(aminomethyl)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-N'-[4-(pyridin- -4-yloxy)phenyl]urea N-{1-[3-(aminomethyl)phenyl]-3-tert-butyl-1H-pyrazol-5-yl}-N'-{2-fluoro-4- -[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}benzyl)acetamide N-[3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)benzyl]acetamide N2-acetyl-N-(3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbon- yl)-amino]-1H-pyrazol-1-yl}benzyl)glycinamide N-(3-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}benzyl)-2-methoxyacetamide N2-acetyl-N-[3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]- phenyl}-amino)carbonyl]amino}-1H-pyrazol-1-yl)benzyl]glycinamide N-[3-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}ami- no)-carbonyl]amino}-1H-pyrazol-1-yl)benzyl]-2-methoxyacetamide N-[3-tert-butyl-1-(3-{[(2,3-dihydroxypropyl)amino]methyl}phenyl)-1H-pyraz- ol-5-yl]-N'-{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-N'-{2-fluoro- -4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-tert-butyl-1-{4-[(2-morpholin-4-ylethoxy)methyl]phenyl}-1H-pyrazol-5- -yl)-N'-{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[4-(methoxymethyl)phenyl]-1H-pyrazol-5-yl}-N'-{2-fluoro- -4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-tert-butyl-1-{4-[(2-morpholin-4-ylethoxy)methyl]phenyl}-1H-pyrazol-5- -yl)-N'-{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[4-(methoxymethyl)phenyl]-1H-pyrazol-5-yl}-N'-{2-fluoro- -4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-(3-tert-butyl-1-{4-[(2-methoxyethoxy)methyl]phenyl}-1H-pyrazol-5-yl)-N'- -{2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea ethyl[4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}- amino)-carbonyl]amino}-1H-pyrazol-1-yl)phenyl]acetate [4-(3-tert-butyl-5-{[({2-fluoro-4-[(2-methylpyridin-4-yl)oxy]phenyl}amino- )-carbonyl]amino}-1H-pyrazol-1-yl)phenyl]acetic acid N-{3-tert-butyl-1-[4-(2-hydroxyethyl)phenyl]-1H-pyrazol-5-yl}-N'-{2-fluor- o-4-[(2-methylpyridin-4-yl)oxy]phenyl}urea N-{3-tert-butyl-1-[4-(2-morpholin-4-yl-2-oxoethyl)phenyl]-1H-pyrazol-5-yl- }-N'-[4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-oxo-2-pyrrolidin-1-ylethyl)phenyl]-1H-pyrazol-5-y- l}-N'-[4-(pyridin-4-yloxy)phenyl]urea N-(3-tert-butyl-1-{4-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]phenyl}-1H-py- razol-5-yl)-N'-[4-(pyridin-4-yloxy)phenyl]urea 2-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-N-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]acetamid- e 2-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]- -1H-pyrazol-1-yl}phenyl)-N-(2-methoxyethyl)acetamide 2-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-N-(2-morpholin-4-ylethyl)acetamide N-[3-tert-butyl-1-(4-{2-[(3R)-3-hydroxypyrrolidin-1-yl]-2-oxoethyl}phenyl- )-1H-pyrazol-5-yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-morpholin-4-ylethyl)phenyl]-1H-pyrazol-5-yl}-N'-[- 4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-pyrrolidin-1-ylethyl)phenyl]-1H-pyrazol-5-yl}-N'-- [4-(pyridin-4-yloxy)phenyl]urea 2-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-N-(2-hydroxyethyl)acetamide N-[3-tert-butyl-1-(4-{2-[(2-hydroxyethyl)amino]ethyl}phenyl)-1H-pyrazol-5- -yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-oxo-2-piperazin-1-ylethyl)phenyl]-1H-pyrazol-5-yl- }-N'-[4-(pyridin-4-yloxy)phenyl]urea N-[3-tert-butyl-1-(4-{2-[(3R)-3-hydroxypyrrolidin-1-yl]ethyl}phenyl)-1H-p- yrazol-5-yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea N-{3-tert-butyl-1-[4-(2-piperazin-1-ylethyl)phenyl]-1H-pyrazol-5-yl}-N'-[- 4-(pyridin-4-yloxy)phenyl]urea 2-(4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-- 1H-pyrazol-1-yl}phenyl)-N-(2,3-dihydroxypropyl)acetamide N-[3-tert-butyl-1-(4-{2-[(2,3-dihydroxypropyl)amino]ethyl}phenyl)-1H-pyra- zol-5-yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea N-[3-tert-butyl-1-(4-{2-[(2-methoxyethyl)amino]ethyl}phenyl)-1H-pyrazol-5- -yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea N-(3-tert-butyl-1-{4-[2-(4-methylpiperazin-1-yl)ethyl]phenyl}-1H-pyrazol-- 5-yl)-N'-[4-(pyridin-4-yloxy)phenyl]urea N-[3-tert-butyl-1-(4-{2-[(2-morpholin-4-ylethyl)amino]ethyl}phenyl)-1H-py- razol-5-yl]-N'-[4-(pyridin-4-yloxy)phenyl]urea or a salt or stereoisomer thereof. 33. A pharmaceutical composition comprising a compound of claim 1, or a pharmaceutically acceptable salt or a stereoisomer thereof, and a physiologically acceptable carrier. 34. A composition of claim 33, further including an additional pharmaceutical agent. 35. A composition of claim 33, further including an additional anti-hyper-proliferative agent. 36. A composition of claim 35, wherein said additional anti-hyper-proliferative agent is epothiline or its derivative, irinotecan, raloxifen or topotecan. 37. A composition of claim 34, wherein said additional pharmaceutical agent is aldesleukin, alendronic acid, alfaferone, alitretinoin, allopurinol, aloprim, aloxi, altretamine, aminoglutethimide, amifostine, amrubicin, amsacrine, anastrozole, anzmet, aranesp, arglabin, arsenic trioxide, aromasin, 5-azacytidine, azathioprine, BCG or tice BCG, bestatin, betamethasone acetate, betamethasone sodium phosphate, bexarotene, bleomycin sulfate, broxuridine, bortezomib, busulfan, calcitonin, campath, capecitabine, carboplatin, casodex, cefesone, celmoleukin, cerubidine, chlorambucil, cisplatin, cladribine, cladribine, clodronic acid, cyclophosphamide, cytarabine, dacarbazine, dactinomycin, DaunoXome, decadron, decadron phosphate, delestrogen, denileukin diftitox, depo-medrol, deslorelin, dexrazoxane, diethylstilbestrol, diflucan, docetaxel, doxifluridine, doxorubicin, dronabinol, DW-166HC, eligard, elitek, ellence, emend, epirubicin, epoetin alfa, epogen, eptaplatin, ergamisol, estrace, estradiol, estramustine phosphate sodium, ethinyl estradiol, ethyol, etidronic acid, etopophos, etoposide, fadrozole, farston, filgrastim, finasteride, fligrastim, floxuridine, fluconazole, fludarabine, 5-fluorodeoxyuridine monophosphate, 5-fluorouracil (5-FU), fluoxymesterone, flutamide, formestane, fosteabine, fotemustine, fulvestrant, gammagard, gemcitabine, gemtuzumab, gleevec, gliadel, goserelin, granisetron HCl, histrelin, hycamtin, hydrocortone, eyrthro-hydroxynonyladenine, hydroxyurea, ibritumomab tiuxetan, idarubicin, ifosfamide, interferon alpha, interferon-alpha 2, interferon alfa-2A, interferon alfa-2B, interferon alfa-n1, interferon alfa-n3, interferon beta, interferon gamma-1a, interleukin-2, intron A, iressa, irinotecan, kytril, lentinan sulphate, letrozole, leucovorin, leuprolide, leuprolide acetate, levamisole, levofolinic acid calcium salt, levothroid, levoxyl, lomustine, lonidamine, marinol, mechlorethamine, mecobalamin, medroxyprogesterone acetate, megestrol acetate, melphalan, menest, 6-mercaptopurine, Mesna, methotrexate, metvix, miltefosine, minocycline, mitomycin C, mitotane, mitoxantrone, Modrenal, Myocet, nedaplatin, neulasta, neumega, neupogen, nilutamide, nolvadex, NSC-631570, OCT-43, octreotide, ondansetron HCl, orapred, oxaliplatin, paclitaxel, pediapred, pegaspargase, Pegasys, pentostatin, picibanil, pilocarpine HCl, pirarubicin, plicamycin, porfimer sodium, prednimustine, prednisolone, prednisone, premarin, procarbazine, procrit, raltitrexed, rebif, rhenium-186 etidronate, rituximab, roferon-A, romurtide, salagen, sandostatin, sargramostim, semustine, sizofuran, sobuzoxane, solu-medrol, sparfosic acid, stem-cell therapy, streptozocin, strontium-89 chloride, synthroid, tamoxifen, tamsulosin, tasonermin, tastolactone, taxotere, teceleukin, temozolomide, teniposide, testosterone propionate, testred, thioguanine, thiotepa, thyrotropin, tiludronic acid, topotecan, toremifene, tositumomab, trastuzumab, treosulfan, tretinoin, trexall, trimethylmelamine, trimetrexate, triptorelin acetate, triptorelin pamoate, UFT, uridine, valrubicin, vesnarinone, vinblastine, vincristine, vindesine, vinorelbine, virulizin, zinecard, zinostatin stimalamer, zofran, ABI-007, acolbifene, actimmune, affinitak, aminopterin, arzoxifene, asoprisnil, atamestane, atrasentan, BAY 43-9006, avastin, CCI-779, CDC-501, celebrex, cetuximab, crisnatol, cyproterone acetate, decitabine, DN-101, doxorubicin-MTC, dSLIM, dutasteride, edotecarin, eflornithine, exatecan, fenretinide, histamine dihydrochloride, histrelin hydrogel implant, holmium-166 DOTMP, ibandronic acid, interferon gamma, intron-PEG, ixabepilone, keyhole limpet hemocyanin, L-651582, lanreotide, lasofoxifene, libra, lonafarnib, miproxifene, minodronate, MS-209, liposomal MTP-PE, MX-6, nafarelin, nemorubicin, neovastat, nolatrexed, oblimersen, onco-TCS, osidem, paclitaxel polyglutamate, pamidronate disodium, PN-401, QS-21, quazepam, R-1549, raloxifene, ranpirnase, 13-cis-retinoic acid, satraplatin, seocalcitol, T-138067, tarceva, taxoprexin, thymosin alpha 1, tiazofurine, tipifarnib, tirapazamine, TLK-286, toremifene, TransMID-107R, valspodar, vapreotide, vatalanib, verteporfin, vinflunine, Z-100, zoledronic acid or combinations thereof.

Details for Patent 7,838,524

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Teknika Llc	TICE BCG	bcg live	For Injection	102821	06/21/1989		2024-04-30
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2024-04-30
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2024-04-30
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2024-04-30
Baxalta Us Inc.	GAMMAGARD, GAMMAGARD S/D, IVEEGAM	immune globulin intravenous (human)	For Injection	103133	02/18/1986		2024-04-30